Log in to save to my catalogue

Understanding hepatitis B, hepatitis C and HIV among people who inject drugs in South Africa: findin...

Understanding hepatitis B, hepatitis C and HIV among people who inject drugs in South Africa: findin...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_2d2b735d25fc4bf6b977b32fe68513f8

Understanding hepatitis B, hepatitis C and HIV among people who inject drugs in South Africa: findings from a three-city cross-sectional survey

About this item

Full title

Understanding hepatitis B, hepatitis C and HIV among people who inject drugs in South Africa: findings from a three-city cross-sectional survey

Publisher

England: BioMed Central Ltd

Journal title

Harm reduction journal, 2019-04, Vol.16 (1), p.28-28, Article 28

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

People who inject drugs (PWID) are at high risk for hepatitis C (HCV), hepatitis B (HBV) and HIV without accessible harm reduction programmes. Coverage of needle and syringe and opioid substitution therapy (OST) services in South Africa is below global recommendations and no hepatitis services exist for PWID. We assessed HCV, HBV and HIV prevalence...

Alternative Titles

Full title

Understanding hepatitis B, hepatitis C and HIV among people who inject drugs in South Africa: findings from a three-city cross-sectional survey

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_2d2b735d25fc4bf6b977b32fe68513f8

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_2d2b735d25fc4bf6b977b32fe68513f8

Other Identifiers

ISSN

1477-7517

E-ISSN

1477-7517

DOI

10.1186/s12954-019-0298-2

How to access this item